Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Damas

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|October 28, 2005
Xanthones--a structural perspectiveL Gales, A M Damas
Journal of Structural Biology|August 15, 2000
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategiesA M Damas, M J Saraiva
The Biochemical Journal|May 5, 2000
Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicityC Redondo, A M Damas, M J Saraiva
The Journal of Biological Chemistry|September 12, 1998
The crystal structure of amyloidogenic Leu55 --> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrilsM P Sebastião, M J Saraiva, A M Damas
Acta Crystallographica. Section D, Biological Crystallography|May 1, 1996
Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant transthyretinP Sebastião, Z Dauter, M J Saraiva, et al.
Journal of Molecular Biology|March 13, 2001
Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolutionM P Sebastião, V Lamzin, M J Saraiva, et al.
The Biochemical Journal|September 22, 2000
The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin 'amyloid-like' oligomer leading to disaggregationM P Sebastião, G Merlini, M J Saraiva, et al.
European Journal of Biochemistry|April 12, 2000
Aprotinin binding to amyloid fibrilsI Cardoso, P J Pereira, A M Damas, et al.
Journal of Molecular Biology|November 25, 2000
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrilsC Redondo, A M Damas, A Olofsson, et al.
Current Drug Targets. CNS and Neurological Disorders|November 4, 2005
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidosesM R Almeida, L Gales, A M Damas, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|October 28, 2005
Xanthones--a structural perspectiveL Gales, A M Damas
Journal of Structural Biology|August 15, 2000
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategiesA M Damas, M J Saraiva
The Biochemical Journal|May 5, 2000
Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicityC Redondo, A M Damas, M J Saraiva
The Journal of Biological Chemistry|September 12, 1998
The crystal structure of amyloidogenic Leu55 --> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrilsM P Sebastião, M J Saraiva, A M Damas
Acta Crystallographica. Section D, Biological Crystallography|May 1, 1996
Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant transthyretinP Sebastião, Z Dauter, M J Saraiva, et al.
Journal of Molecular Biology|March 13, 2001
Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolutionM P Sebastião, V Lamzin, M J Saraiva, et al.
The Biochemical Journal|September 22, 2000
The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin 'amyloid-like' oligomer leading to disaggregationM P Sebastião, G Merlini, M J Saraiva, et al.
European Journal of Biochemistry|April 12, 2000
Aprotinin binding to amyloid fibrilsI Cardoso, P J Pereira, A M Damas, et al.
Journal of Molecular Biology|November 25, 2000
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrilsC Redondo, A M Damas, A Olofsson, et al.
Current Drug Targets. CNS and Neurological Disorders|November 4, 2005
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidosesM R Almeida, L Gales, A M Damas, et al.
Pageof 2